IL10 and colitis: using antigen-activated CD4+ T cells cultured in the presence of IL-10 led to the identification of a distinct T cell subset, thereafter named TR1, that could prevent the development of experimental colitis in an IL-10- and transforming growth factor beta (TGFβ)-dependent manner (2).